rxstatShortages › Esomeprazole Naproxen

Esomeprazole Naproxen (Vimovo) shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Esomeprazole Naproxen is in a widespread shortage in Canada. 2 of 3 reported products are affected. The latest manufacturer estimate for full recovery is Nov 24, 2026.

A combination of an anti-inflammatory pain reliever and an acid reducer, used for arthritis pain while protecting the stomach.

Products affected
2 / 3
In shortage since
Mar 4, 2026
Est. full return
Nov 24, 2026
Reports on file
33
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · since Mar 4, 2026, est. end Nov 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 375MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02458608 · since Mar 13, 2026, est. end Nov 24, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Aug 18, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Jul 23, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Jul 8, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Apr 21, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 375MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02458608 · ended Mar 13, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Feb 10, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 500MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02443449 · ended Feb 1, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
20MG 375MG · TABLET (IMMEDIATE AND DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02458608 · ended Jan 11, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 33 reports. All reports are on file with Health Canada.

What's happening

Esomeprazole Naproxen is currently affected by 2 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Esomeprazole Naproxen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).

Recent changes

Common questions

What is Esomeprazole Naproxen used for?

A combination of an anti-inflammatory pain reliever and an acid reducer, used for arthritis pain while protecting the stomach.

When will Esomeprazole Naproxen be back in stock in Canada?

The latest manufacturer estimate is Nov 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Esomeprazole Naproxen in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiinflammatory/antirheumatic prod.,non-steroids)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.